Journal of Clinical Endocrinology & Metabolism, Vol 65, 665-670, Copyright © 1987 by Endocrine Society

ARTICLES

Human retroocular fibroblasts in vitro: a model for the study of Graves' ophthalmopathy

RS Bahn, CA Gorman, GE Woloschak, CS David, PM Johnson and CM Johnson
Department of Internal Medicine, Immunology, and Pediatrics, Mayo Clinic/Foundation, Rochester, Minnesota 55905.

Orbital connective tissue and extraocular muscles are histologically abnormal in patients with Graves' ophthalmopathy (GO). Although extraocular muscles have been extensively studied as a target for autoimmune attack in the disease, no system has been available to study retroocular fibroblasts in GO. We developed a technique to isolate fibroblasts from minced explants of connective tissue removed in the course of transantral orbital decompression surgery for GO. Postmortem specimens from individuals without evidence of thyroid disease were obtained from the same anatomical site. Confluent cells could be passaged at least 10 times with stable morphology and frozen with greater than 75% viability. An enzyme-linked immunosorbent assay was used to study the in vitro binding of serum immunoglobulin G (IgG) to these cells. We found no difference in the degree of specific binding between GO cells and cells from normal individuals. However, there was significantly greater binding of IgG from GO sera than of that from normal serum to retroocular GO fibroblasts. These results suggest that serum IgG autoantibodies against normal retroocular fibroblasts are present in some GO patients.

This article has been cited by other articles:

				T. J. Cawood, P. Moriarty, C. O'Farrelly, and D. O'Shea Smoking and Thyroid-Associated Ophthalmopathy: A Novel Explanation of the Biological Link J. Clin. Endocrinol. Metab., January 1, 2007; 92(1): 59 - 64. [Abstract] [Full Text] [PDF]

				T J Cawood, P Moriarty, C O'Farrelly, and D O'Shea The effects of tumour necrosis factor-{alpha} and interleukin1 on an in vitro model of thyroid-associated ophthalmopathy; contrasting effects on adipogenesis Eur. J. Endocrinol., September 1, 2006; 155(3): 395 - 403. [Abstract] [Full Text] [PDF]

				P. Agretti, G. De Marco, M. De Servi, C. Marcocci, P. Vitti, A. Pinchera, and M. Tonacchera Evidence for protein and mRNA TSHr expression in fibroblasts from patients with thyroid-associated ophthalmopathy (TAO) after adipocytic differentiation Eur. J. Endocrinol., May 1, 2005; 152(5): 777 - 784. [Abstract] [Full Text] [PDF]

				R. W. Valyasevi, S. C. Jyonouchi, C. M. Dutton, N. Munsakul, and R. S. Bahn Effect of Tumor Necrosis Factor-{{alpha}}, Interferon-{{gamma}}, and Transforming Growth Factor-{beta} on Adipogenesis and Expression of Thyrotropin Receptor in Human Orbital Preadipocyte Fibroblasts J. Clin. Endocrinol. Metab., February 1, 2001; 86(2): 903 - 908. [Abstract] [Full Text]

				T. Mühlberg, W. Joba, C. Spitzweg, H.-D. Schworm, H.-J. Heberling, and A. E. Heufelder Interleukin-1 Receptor Antagonist Ribonucleic Acid and Protein Expression by Cultured Graves' and Normal Orbital Fibroblasts Is Differentially Modulated by Dexamethasone and Irradiation J. Clin. Endocrinol. Metab., February 1, 2000; 85(2): 734 - 742. [Abstract] [Full Text]

				R. S. Bahn, C. M. Dutton, N. Natt, W. Joba, C. Spitzweg, and A. E. Heufelder Thyrotropin Receptor Expression in Graves' Orbital Adipose/Connective Tissues: Potential Autoantigen in Graves' Ophthalmopathy J. Clin. Endocrinol. Metab., March 1, 1998; 83(3): 998 - 1002. [Abstract] [Full Text]

				R. S. Bahn and A. E. Heufelder Pathogenesis of Graves' Ophthalmopathy N. Engl. J. Med., November 11, 1993; 329(20): 1468 - 1475. [Full Text]